Medicare Enrolled
Dr. Marina Anne Martyn, MD
Internal Medicine · Oneida, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martyn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martyn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martyn
Dr. Marina Anne Martyn is an internal medicine specialist in Oneida, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martyn performed 3,059 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Martyn received a total of $13,239 from 52 pharmaceutical and/or device companies across 725 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martyn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in NY
$13,239 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,059
Medicare services
Top 11% in NY for internal medicine
Not available
Unique patients (not deduplicated)
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,500 | $16 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
725 | $83 | $167 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
212 | $124 | $195 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
186 | $57 | $117 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
93 | $9 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
60 | $11 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
54 | $116 | $202 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
35 | $30 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
29 | $66 | $67 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
25 | $58 | $89 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
25 | $156 | $235 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
24 | $127 | $162 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $57 | $150 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
21 | $50 | $67 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $35 | $79 |
| Nursing facility discharge management, 30 minutes or less This service covers the management of a patient's discharge from a nursing facility. It applies when the total time spent on discharge activities is 30 minutes or less. |
14 | $51 | $70 |
| Stool test for hidden blood (FIT) A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method. |
13 | $16 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,239
Total received (2018-2024)
Avg $1,891/year across 7 years
Top 7% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
725
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,938
2023
$2,129
2022
$2,128
2021
$1,840
2020
$1,124
2019
$1,578
2018
$1,502
Payments by company (2024)
Janssen Biotech, Inc.
$723
Amgen Inc.
$421
ABBVIE INC.
$402
GlaxoSmithKline, LLC.
$269
Novartis Pharmaceuticals Corporation
$202
AstraZeneca Pharmaceuticals LP
$146
Paratek Pharmaceuticals, Inc.
$127
UCB, Inc.
$97
Astellas Pharma US Inc
$90
PFIZER INC.
$83
Novo Nordisk Inc
$62
Lilly USA, LLC
$62
Baxter Healthcare
$55
IBSA Pharma Inc.
$52
Abbott Laboratories
$34
ALK-Abello, Inc
$31
Merck Sharp & Dohme LLC
$23
Phathom Pharmaceuticals, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Organon Llc
$16
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,596
Janssen Biotech, Inc.
$1,424
PFIZER INC.
$1,168
AstraZeneca Pharmaceuticals LP
$997
ABBVIE INC.
$996
GlaxoSmithKline, LLC.
$954
Novartis Pharmaceuticals Corporation
$914
Boehringer Ingelheim Pharmaceuticals, Inc.
$552
AbbVie Inc.
$475
Lilly USA, LLC
$438
Novo Nordisk Inc
$438
Astellas Pharma US Inc
$417
Janssen Pharmaceuticals, Inc
$350
Genentech USA, Inc.
$261
AbbVie, Inc.
$209
Merck Sharp & Dohme Corporation
$202
Paratek Pharmaceuticals, Inc.
$173
Biohaven Pharmaceuticals, Inc.
$153
Abbott Laboratories
$124
IBSA Pharma Inc.
$117
E.R. Squibb & Sons, L.L.C.
$100
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$99
Merck Sharp & Dohme LLC
$98
UCB, Inc.
$97
Amarin Pharma Inc.
$94
Biohaven Pharmaceutical Holding Company Ltd.
$87
Takeda Pharmaceuticals U.S.A., Inc.
$58
Baxter Healthcare
$55
Mylan Specialty L.P.
$51
Horizon Therapeutics plc
$50
Shield Therapeutics Inc
$47
GENZYME CORPORATION
$45
IDORSIA PHARMACEUTICALS US INC
$42
Janssen Scientific Affairs, LLC
$33
ALK-Abello, Inc
$31
SANOFI-AVENTIS U.S. LLC
$26
Bardy Diagnostics, Inc.
$23
Phathom Pharmaceuticals, Inc.
$23
Sandoz Inc.
$22
Renalytix AI, Inc.
$21
Teva Pharmaceuticals USA, Inc.
$19
Nestle HealthCare Nutrition Inc.
$17
Organon Llc
$16
Edwards Lifesciences Corporation
$15
Optinose US, Inc.
$15
Grifols USA, LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$15
Circassia Pharmaceuticals Inc
$14
Fresenius Kabi USA, LLC
$14
Celgene Corporation
$14
Collegium Pharmaceutical, Inc.
$13
Gilead Sciences, Inc.
$11
Top 3 companies account for 31.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · AMJEVITA · ANORO · ANORO ELLIPTA · Aimovig · BELSOMRA · BENLYSTA · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · COMIRNATY · COSENTYX · CREON · CYLTEZO · Carnation Ambulatory Monitor · Cimzia · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edwards SAPIEN 3 Transcatheter Heart Valve · Enbrel · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GARDASIL · HADLIMA · HUMIRA · HYRIMOZ · Hillrom - Cardiac Ambulatory Monitor · Humira · IDACIO · ILARIS · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · LEQVIO · LICART · LINZESS · LOKELMA · LYRICA · MOUNJARO · MYRBETRIQ · NURTEC ODT · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Odactra · Otezla · Ozempic · PENNSAID · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Prolastin-C Liquid · QULIPTA · QUVIVIQ · RAYOS · REMICADE · RINVOQ · RYBELSUS · Repatha · Rinvoq · Rituxan · Rybelsus · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SKYRIZI · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Saxenda · TALTZ · TAVNEOS · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TREMFYA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tirosint · Tresiba · Trintellix · UBRELVY · VESICARE · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · XARELTO · XELJANZ · XIFAXAN · XTAMPZA · Xhance · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
283
County median income
$73,141
Nearest hospital to ZIP centroid (approximate)
ONEIDA HEALTH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martyn is a clinical cardiology specialist, with above-average Medicare volume (top 11% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martyn experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Martyn performed 1,500 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Martyn receive payments from pharmaceutical companies?
Yes. Dr. Martyn received a total of $13,239 from 52 companies across 725 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martyn's costs compare to other internal medicine physicians in Oneida?
Dr. Martyn's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martyn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Oneida
Browse internal medicine physicians in Oneida ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NY
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NY
Which NY internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology